` 600488 (Tianjin Tianyao Pharmaceuticals Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

T
600488
vs
S
Shanghai Composite

Over the past 12 months, Tianjin Tianyao Pharmaceuticals Co Ltd has underperformed Shanghai Composite, delivering a return of +0% compared to the Shanghai Composite's +26% growth.

Stocks Performance
600488 vs Shanghai Composite

Loading
600488
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
600488 vs Shanghai Composite

Loading
600488
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
600488 vs Shanghai Composite

Loading
600488
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Tianjin Tianyao Pharmaceuticals Co Ltd vs Peers

Shanghai Composite
600488
JEF
JNJ
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Tianjin Tianyao Pharmaceuticals Co Ltd
Glance View

Market Cap
4.7B CNY
Industry
Pharmaceuticals

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, development, production, and sales of corticosteroids and amino acid raw materials and preparations. The company is headquartered in Tianjin, Tianjin and currently employs 2,635 full-time employees. The company went IPO on 2001-06-18. The firm's primary products include corticosteroid bulk pharmaceutical chemicals (BPCs), amino acid BPCs and intermediate, such as dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinolone acetate, prednisone acetate, triamcinolone acetonide, propranolol propionate and betamethasone, among others. The firm mainly distributes its products in domestic and overseas markets.

Intrinsic Value
4.01 CNY
Overvaluation 6%
Intrinsic Value
Price
T
Back to Top